A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Murthy GSG, Saliba AN, Szabo A, Harrington A, Abedin S, Carlson K, Michaelis L, Runaas L, Baim A, Hinman A, Maldonado-Schmidt S, Venkatachalam A, Flatten KS, Peterson KL, Schneider PA, Litzow M, Kaufmann SH, Atallah E.
Murthy GSG, et al. Among authors: runaas l.
Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2024.285014. Online ahead of print.
Haematologica. 2024.
PMID: 38572562
Free article.